Molina Healthcare, Inc., recently shared some notable results of a groundbreaking health care model that uses artificial intelligence (AI) to impact the full cycle of obstetrical care, from early pregnancy detection to post-NICU community-based care management. The result of a partnership between Molina, Lucina Analytics, and Progeny Health, the new model demonstrated results in nearly 150,000 patients over an 18-month period, including an 8% decrease in preterm births compared to n

Pearl, the global leader in dental AI solutions, today announced that its Second Opinion® chairside dental pathology detection aid has been granted a certification recommendation as a Class IIa medical device under the European Union Medical Device Regulation (Regulation (EU) 2017/745) (EU-MDR). The certification, issued by GMED SAS on June 6, 2023, makes Pearl the first company worldwide in the industry of AI-driven computer aided dental detection software to obtain the new European Medi

Masimo and Community Health System, based in Fresno, California, today announced that CHS is adopting a variety of advanced Masimo monitoring technologies and solutions across its campuses. CHS, a large four-hospital network, provides all levels of care across the Central Valley area of California, and is standardizing on Masimo SET® pulse oximetry and deploying 800 Root® Vital Signs Monitoring and Connectivity Hubs and 200 Rad-97® Pulse CO-Oximeters® with NomoLine® capnog

Parthenon Therapeutics, a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment, today announced that the Journal for ImmunoTherapy of Cancer (JITC) has published results from an international panel of cancer experts convened to provide an initial consensus on the role of immune exclusion in cancer. The article “Developing a Definition of Immune Exclusion in Cancer: Results of a Modified Delphi Workshop,&rdqu

SoftServe, a global IT consulting firm, today announced its acquisition of Hoverstate, a full-service digital agency specializing in mobile and web-based solutions. The acquisition positions both companies as a single software solution source for digital native organizations. SoftServe’s dynamic offerings and global footprint enhance Hoverstate’s intelligent process automation expertise and its key partnership with the Pega Platform from Pegasystems, the low-code platfor

Clarify Health, an an innovative leader in healthcare analytics and value-based payment solutions, is thrilled to announce the closed beta launch of its revolutionary generative artificial intelligence (AI), Clara. This groundbreaking technology is set to empower healthcare delivery organizations to access insights into influenceable behavior changes that matter the most in lowering the cost and improving the quality of healthcare – at a fraction of the time it traditionally takes.

AIDS Healthcare Foundation welcomes the decision by the European Union to reduce antimicrobial resistance by 20% in the bloc by 2030. As part of the push, the strategy should discourage widespread use of pre- and post-exposure prophylaxis as the primary method of prevention for sexually transmitted infections (STI) in favor of promoting consistent condom use. “Wealthy countries are courting another public health disaster by abandoning condoms and shifting STI prevention to bio

Capnopharm is proud to announce that its new CapnoPen® CP-001k received CE certification (MDR) for aerosolizing chemotherapy, DNA, RNA, nanomolecules, viruses, and immunotherapy into body cavities. As the only nebulizer with such certification, the new CapnoPen® is setting a new regulatory standard in Intraperitoneal Chemotherapy. Stephane Rohan Laurent, Capnopharm’s VP Sales & Business Development, comments: “Receiving CE certification constitutes a landmark

FogPharma®, a biopharmaceutical company committed to transforming the lives of patients through a new precision medicine approach widely applicable to important and challenging intracellular targets, today announced the first patient has been dosed in a first-in-human Phase 1/2 clinical trial of, FOG-001, the company’s first-in-class TCF-blocking β-catenin inhibitor. FOG-001 represents the first development candidate arising from FogPharma’s pioneering Helicon™ ther

PDI International - a global organisation focused on preventing infections in healthcare, hospitality and other communities – has been awarded the Medtop Clinic Award for Best Customer Support Project. The company, which is headquartered in the UK, was presented the award for their unique approach to customer services, delivering impact through science led innovation, training and education. Uniquely the company has a SMART Layered Approach to infection prevention, t